Boston Scientific (BSX) stock forecast for 2023
Last update: 06-24-2022, 9:47Sector: Healthcare
The share price of Boston Scientific Corp. (BSX) now
What analysts predict:: $49.82
52-week high/low: $47.5 / $34.98
50/200 Day Moving Average: $40.77 / $42.41
This figure corresponds to the average price over the previous 50/200 days. For Boston Scientific stocks, the 50-day moving average is the resistance level today.
For Boston Scientific stocks, the 200-day moving average is the resistance level today.
Are you interested in Boston Scientific stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Boston Scientific stock price in 2023. How much will one Boston Scientific share be worth in 2023?
Is it worth taking profit / loss on Boston Scientific stock now or waiting? What are analysts' forecasts for Boston Scientific stock?
We forecast Boston Scientific stock performance using neural networks based on historical data on Boston Scientific stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Boston Scientific stock prediction results are shown below and presented as a graph, table and text information.
Boston Scientific stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Boston Scientific analysts is $49.82.
Today 200 Day Moving Average is the resistance level (42.41 $).
50 Day Moving Average is the resistance level (40.77 $).
Historical and forecast chart of Boston Scientific stock
The chart below shows the historical price of Boston Scientific stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Boston Scientific stock price can be found in the table below.
Boston Scientific (BSX) Forecast for 2023
Boston Scientific information and performance
Boston Scientific Corporation is a global creator, manufacturer and marketer of medical devices, their products are used in the interventional fields of medicine including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular interventions, electrophysiology, cardiovascular surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The manufacturer is famous for its Taxus stent, which contains the medication Paclitaxel and is used for clogged arteries.
Boston Scientific was formed in June 1979 under the name Medi-Tech and immediately positioned itself as a company for growth in interventional medicine. In April 2006, the firm acquired its former rival Guidant for $ 27.2 billion, and the former Guidant was split between BSC and Abbott Laboratories. In 2008, another major major firm, MAQUET, takes over the cardiac and vascular surgery department of the Boston Scientific Corporation. American businessman John Abel (director) together with Peter Nicholas (chairman) are the founders of BSC.
Boston Scientific Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, US
Market Capitalization: 52 936 978 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 3 224 000 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 69.87
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 2.156
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: -0.705
Quarterly Revenue Growth YOY: 0.1
Trailing PE: 69.87
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 20.62
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 5.04
Enterprise Value (EV) /Revenue
EV To EBITDA: 24.08
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 1429570000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Boston Scientific price target for 2021 by month
Target values for the price of one Boston Scientific share for Jan 2023.
Pessimistic target level: 39.30
Optimistic target level: 41.84
Target values for the price of one Boston Scientific share for Feb 2023.
Pessimistic target level: 38.66
Optimistic target level: 41.70
Target values for the price of one Boston Scientific share for Mar 2023.
Pessimistic target level: 38.13
Optimistic target level: 41.14
Target values for the price of one Boston Scientific share for Apr 2023.
Pessimistic target level: 39.98
Optimistic target level: 42.66
Target values for the price of one Boston Scientific share for May 2023.
Pessimistic target level: 37.91
Optimistic target level: 41.06
Target values for the price of one Boston Scientific share for Jun 2023.
Pessimistic target level: 38.71
Optimistic target level: 42.25
Target values for the price of one Boston Scientific share for Jul 2023.
Pessimistic target level: 38.00
Optimistic target level: 40.31
Target values for the price of one Boston Scientific share for Aug 2023.
Pessimistic target level: 37.39
Optimistic target level: 40.00
Target values for the price of one Boston Scientific share for Sep 2023.
Pessimistic target level: 37.48
Optimistic target level: 39.95
Target values for the price of one Boston Scientific share for Oct 2023.
Pessimistic target level: 36.87
Optimistic target level: 39.89
Target values for the price of one Boston Scientific share for Nov 2023.
Pessimistic target level: 36.92
Optimistic target level: 40.02
Target values for the price of one Boston Scientific share for Dec 2023.
Pessimistic target level: 38.28
Optimistic target level: 41.84
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.